| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Physiology and Biophysics, School of Medicine, University of Alabama in Birmingham Birmingham, Alabama 35294
Abstract
Although the extent of proptosis in exophthalmic Graves' disease has been measured directly and shown to correlate with serum content of a bioassayable exophthalmos-producing factor (EPF;1), a comparable relationship in an experimental model has not been reported. Progressive exophthalmos, measured from photographs and expressed as a ratio of intercorneal distance to intersupraorbital ridge distance, was produced in male guinea pigs when thyroid status was altered either by surgical thyroidectomy supplemented with 131I treatment or by the administration of 6-propyl-2 thiouracil (0.1% in chow). In both groups, at time of sacrifice, serum content of EPF estimated by a modified goldfish bioassay using a known exophthalmogenic TSH preparation (Ambinon®, Organon-Oss) as standard was positively correlated (r = 0.804) with the terminal degree of exophthalmos. Daily replacement therapy with T4(15 µg/kg body wt) failed to alter significantly the exophthalmos which developed, even when replacement was initiated prior to the alterations of thyroid gland function; this observation tends to eliminate thyroid hormone deficiency per se as the causal event in exophthalmos. T4treatment did, however, reverse or prevent the rises in serum TSH levels (McKenzie bioassay) thus dissociating TSH activity from EPF activity in the guinea pig. Treatment of guinea pigs with synthetic TRH (0.5, 1.0 or 10 µtg/kg body wt) for 21 days failed to produce demonstrable exophthalmos or assayable EPF levels although plasma TSH was significantly elevated. (Endocrinology 96: 151, 1975)
Footnotes
1 This study was supported in part by institutional General Research Support grants from the NIH, by an institutional grant for science from NSF and by funds from the UAB Granduate School.
2 A preliminary report of this investigation was reported at the 1972 FASEB MEETINGS (Fed Proc 31: 276, 1972).
3 Current address: Department of Physiology and Biophysics, University of Tennessee Medical Units,Memphis, Tennessee.
4 Address reprint requests to Dr. Taylor.
Received January 14, 1974.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |